Ausgabe 3/2016
Inhalt (24 Artikel)
Brain metastasis in breast cancer: a comprehensive literature review
Rezvan Rostami, Shivam Mittal, Pooya Rostami, Fattaneh Tavassoli, Bahman Jabbari
The challenges associated with molecular targeted therapies for glioblastoma
Toni Rose Jue, Kerrie L. McDonald
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system
Johannes van de Nes, Marco Gessi, Antje Sucker, Inga Möller, Mathias Stiller, Susanne Horn, Simone L. Scholz, Carina Pischler, Nadine Stadtler, Bastian Schilling, Lisa Zimmer, Uwe Hillen, Richard A. Scolyer, Michael E. Buckland, Libero Lauriola, Torsten Pietsch, Andreas Waha, Dirk Schadendorf, Rajmohan Murali, Klaus G. Griewank
The effects of antiepileptic drugs on the growth of glioblastoma cell lines
Ching-Yi Lee, Hung-Yi Lai, Angela Chiu, She-Hung Chan, Ling-Ping Hsiao, Shih-Tseng Lee
Long-term exposure to irinotecan reduces cell migration in glioma cells
A. B. Al-Ghafari, W. Punjaruk, L. C. D. Storer, D. J. Carrier, D. Hussein, B. Coyle, I. D. Kerr
Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy
James R. Hands, Graeme Clemens, Ryan Stables, Katherine Ashton, Andrew Brodbelt, Charles Davis, Timothy P. Dawson, Michael D. Jenkinson, Robert W. Lea, Carol Walker, Matthew J. Baker
In vivo multiphoton tomography and fluorescence lifetime imaging of human brain tumor tissue
Sven R. Kantelhardt, Darius Kalasauskas, Karsten König, Ella Kim, Martin Weinigel, Aisada Uchugonova, Alf Giese
Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma
Soma Ghasimi, Carl Wibom, Anna M. Dahlin, Thomas Brännström, Irina Golovleva, Ulrika Andersson, Beatrice Melin
The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?
D. T. Blumenthal, L. Mendel, F. Bokstein
Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?
D. T. Blumenthal, L. Mendel, F. Bokstein
Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide
Navid Redjal, Clemens Reinshagen, Andrew Le, Brian P. Walcott, Erin McDonnell, Jorg Dietrich, Brian V. Nahed
Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI
Moran Artzi, Gilad Liberman, Guy Nadav, Deborah T. Blumenthal, Felix Bokstein, Orna Aizenstein, Dafna Ben Bashat
Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer
Ren Yuan, Andrew Yamada, Britta Weber, Cheryl Ho
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas
Wenyin Shi, Joshua D. Palmer, Maria Werner-Wasik, David W. Andrews, James J. Evans, Jon Glass, Lyndon Kim, Voichita Bar-Ad, Kevin Judy, Christopher Farrell, Nicole Simone, Haisong Liu, Adam P. Dicker, Yaacov R. Lawrence
The modified lateral supraorbital approach for tumors of the petroclival junction extending into the anterior cerebellopontine area
Jaejoon Lim, Kyunggi Cho
Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery
Amir Zolal, Tareq A. Juratli, Jennifer Linn, Dino Podlesek, Kerim Hakan Sitoci Ficici, Hagen H. Kitzler, Gabriele Schackert, Stephan B. Sobottka, Bernhard Rieger, Dietmar Krex
Cognitive screening in patients with intracranial tumors: validation of the BCSE
Juliane Becker, Elisabeth Steinmann, Maria Könemann, Sonja Gabske, Hubertus Maximilian Mehdorn, Michael Synowitz, Gesa Hartwigsen, Simone Goebel
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial
Carmen Balana, Ramon De Las Penas, Juan Manuel Sepúlveda, Miguel J. Gil-Gil, Raquel Luque, Oscar Gallego, Cristina Carrato, Carolina Sanz, Gaspar Reynes, Ana Herrero, Jose Luis Ramirez, Pedro Pérez-Segura, Alfonso Berrocal, Jose Maria Vieitez, Almudena Garcia, Sergio Vazquez-Estevez, Sergi Peralta, Isaura Fernandez, Ivan Henriquez, Maria Martinez-Garcia, Juan Jose De la Cruz, Jaume Capellades, Pilar Giner, Salvador Villà
Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles?
Sebastian Adeberg, Christian Diehl, Carla S. Jung, Stefan Rieken, Stephanie E. Combs, Andreas Unterberg, Jürgen Debus
“Comet tail sign”: A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors
Koichi Mitsuya, Yoko Nakasu, Yoshitaka Narita, Satoshi Nakasu, Makoto Ohno, Yasuji Miyakita, Masato Abe, Ichiro Ito, Nakamasa Hayashi, Masahiro Endo
Optic toxicity in radiation treatment of meningioma: a retrospective study in 213 patients
Mostafa Farzin, Michael Molls, Severin Kampfer, Sabrina Astner, Ralf Schneider, Karin Roth, Michaela Dobrei, Stephanie Combs, Christoph Straube
Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases
Amparo Wolf, Sayyad Zia, Rashika Verma, Anna Pavlick, Melissa Wilson, John G. Golfinos, Joshua S. Silverman, Douglas Kondziolka
Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach
Giordano Savelli, Mirco Bartolomei, Mario Bignardi